XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Balance at beginning of period (shares) at Dec. 31, 2017   28,622,886      
Balance at beginning of period at Dec. 31, 2017 $ 143,288 $ 29 $ 594,407 $ 9,479 $ (460,627)
Increase (Decrease) in Stockholders' Equity          
Net loss for the period (42,578)       (42,578)
Issuance of common stock, net of issuance costs (shares)   3,162,500      
Issuance of common stock, net of issuance costs 130,660 $ 3 130,657    
Share-based compensation expense 7,534   7,534    
Issuance of common stock from ESPP (shares)   14,246      
Issuance of common stock from ESPP $ 202   202    
Exercise of options for cash (shares) 513,808 513,808      
Exercise of options for cash $ 7,372   7,372    
Unrealized gain (loss) on investments (134)     (134)  
Balance at end of period (shares) at Jun. 30, 2018   32,313,440      
Balance at end of period at Jun. 30, 2018 246,344 $ 32 740,172 9,345 (503,205)
Balance at beginning of period (shares) at Mar. 31, 2018   29,025,834      
Balance at beginning of period at Mar. 31, 2018 137,841 $ 29 603,957 9,191 (475,336)
Increase (Decrease) in Stockholders' Equity          
Net loss for the period (27,869)       (27,869)
Issuance of common stock, net of issuance costs (shares)   3,162,500      
Issuance of common stock, net of issuance costs 130,660 $ 3 130,657    
Share-based compensation expense 3,874   3,874    
Issuance of common stock from ESPP (shares)   14,246      
Issuance of common stock from ESPP $ 202   202    
Exercise of options for cash (shares) 110,860 110,860      
Exercise of options for cash $ 1,482   1,482    
Unrealized gain (loss) on investments 154     154  
Balance at end of period (shares) at Jun. 30, 2018   32,313,440      
Balance at end of period at Jun. 30, 2018 $ 246,344 $ 32 740,172 9,345 (503,205)
Balance at beginning of period (shares) at Dec. 31, 2018 32,538,857 32,538,857      
Balance at beginning of period at Dec. 31, 2018 $ 201,576 $ 33 751,109 9,479 (559,045)
Increase (Decrease) in Stockholders' Equity          
Net loss for the period (86,607)       (86,607)
Issuance of common stock, net of issuance costs (shares)   4,269,838      
Issuance of common stock, net of issuance costs 327,810 $ 5 327,805    
Share-based compensation expense 23,720   23,720    
Issuance of common stock from ESPP (shares)   9,844      
Issuance of common stock from ESPP $ 323   323    
Exercise of options for cash (shares) 332,887 332,887      
Exercise of options for cash $ 4,300   4,300    
Proceeds from disgorgement of stockholders' short-swing profits $ 1,050   1,050    
Net exercise of warrants (shares) 1,400,000 1,400,000      
Net exercise of warrants $ 0 $ 1 (1)    
Unrealized gain (loss) on investments $ 309     309  
Balance at end of period (shares) at Jun. 30, 2019 38,551,426 38,551,426      
Balance at end of period at Jun. 30, 2019 $ 472,481 $ 39 1,108,306 9,788 (645,652)
Balance at beginning of period (shares) at Mar. 31, 2019   36,029,093      
Balance at beginning of period at Mar. 31, 2019 283,554 $ 36 873,838 9,637 (599,957)
Increase (Decrease) in Stockholders' Equity          
Net loss for the period (45,695)       (45,695)
Issuance of common stock, net of issuance costs (shares)   2,415,000      
Issuance of common stock, net of issuance costs 219,927 $ 3 219,924    
Share-based compensation expense 12,589   12,589    
Issuance of common stock from ESPP (shares)   9,844      
Issuance of common stock from ESPP $ 323   323    
Exercise of options for cash (shares) 97,489 97,489      
Exercise of options for cash $ 1,632   1,632    
Unrealized gain (loss) on investments $ 151     151  
Balance at end of period (shares) at Jun. 30, 2019 38,551,426 38,551,426      
Balance at end of period at Jun. 30, 2019 $ 472,481 $ 39 $ 1,108,306 $ 9,788 $ (645,652)